Executive Director, Clinical Pharmacokinetics

Role: Executive Director of Clinical Pharmacokinetics, providing strategic leadership for PK and pharmacometrics across biopharma drug development stages, primarily focusing on pulmonary hypertension therapies. Responsibilities: develop integrated PK strategies from early to late-stage development; translate preclinical and clinical PK data into development and dosing recommendations; oversee PK study design, execution, and modeling, including population PK and exposure-response analyses; lead inhaled drug PK strategies; support regulatory interactions and submissions; collaborate with multidisciplinary teams internally and externally. Requirements: PhD or equivalent in Pharmacokinetics, Pharmacology, or related fields; extensive experience in clinical pharmacokinetics/pharmacology, PK strategy development, modeling, and regulatory submissions; strong cross-functional leadership in biotech/pharma setting; excellent communication of complex PK concepts. HighValue: expertise in inhaled therapies, PK modeling, drug development lifecycle, regulatory engagement, and cross-disciplinary collaboration within clinical pharmacology and development teams.